Internal Medicine, Endocrinology, Diabetes, & Metabolism · Chicago, IL
NPI
1477994358
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1650 W Harrison St, Suite 466 Atrium
Chicago, IL, 60612
Phone (312) 659-7074
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,529 services
Medicare patients, 2024
361
Average age 72
Drug cost, 2024
$2.0M
3,899 prescriptions
Company payments, 2025
$85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Morkos was code 99214 (office e&m - established), 484 times for 278 patients. In total Michael Morkos billed 1,529 services in 17 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 484 | 278 | $86.27 | $42K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 470 | 257 | $11.66 | $5,481 |
| 95251 Test - Miscellaneous | Office | 194 | 70 | $24.23 | $4,700 |
| 99215 Office E&M - Established | Office | 173 | 94 | $125.95 | $22K |
| 83036 Blood Count | Office | 75 | 58 | $9.52 | $714 |
| 99232 Hospital E&M - Subsequent | Facility | 32 | 20 | $58.11 | $1,860 |
| 99204 Office E&M - New | Office | 31 | 31 | $114.30 | $3,543 |
| 99205 Office E&M - New | Office | 11 | 11 | $141.64 | $1,558 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $95.60 | $1,052 |
By year: 2022 $75K for 1,023 services; 2023 $70K for 983 services; 2024 $88K for 1,529 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 75 | 58 | $9.52 | $714 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Morkos prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 338 prescriptions and refills. In total Michael Morkos wrote 3,899 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 338 | 510 | 60 | $559K |
| Methimazole Generic | 320 | 706 | 76 | $3,512 |
| Levothyroxine Sodium Generic | 264 | 724 | 83 | $2,450 |
| Levoxyl Levothyroxine Sodium | 242 | 611 | 63 | $9,755 |
| Alendronate Sodium Generic | 161 | 413 | 50 | $3,302 |
| Ozempic Semaglutide | 149 | 240 | 31 | $222K |
| Jardiance Empagliflozin | 143 | 274 | 29 | $163K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 142 | 318 | 43 | $21K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 138 | 292 | 48 | $14K |
| Metformin Hcl Generic | 125 | 338 | 34 | $1,056 |
| Novolog Flexpen Insulin Aspart | 100 | 184 | 29 | $32K |
| Humalog Kwikpen U-100 Insulin Lispro | 92 | 220 | 31 | $45K |
| Rosuvastatin Calcium Generic | 89 | 253 | 25 | $1,523 |
| Tresiba Flextouch U-100 Insulin Degludec | 89 | 213 | 27 | $79K |
| Synthroid Levothyroxine Sodium | 77 | 206 | 21 | $7,415 |
Brand drugs: 2,064 claims; generic drugs: 1,511 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Morkos $85 ($85 in general payments such as food, travel and fees) from 1 company. The largest payer was Mannkind Corporation with $85.
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation MNKD | 2 | $85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.